XML 255 R10.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Sep. 26, 2025
Sep. 27, 2024
Sep. 29, 2023
Operating activities:      
Net income including controlling interest $ 256,492 $ 264,316 $ 201,644
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 87,827 75,559 82,558
Stock-based compensation 128,514 119,825 118,486
Amortization of operating lease right-of-use assets 10,770 11,768 12,956
Amortization of premium on investments 0 (2,919) (860)
Provision for doubtful accounts 2,434 (2,256) (793)
Deferred income taxes 4,988 (21,612) (18,337)
Impairment loss on internally developed software 0 0 16,225
Share of net income of equity method investees, net of cash distributions (707) (2,023) (60)
Other non-cash items affecting net income (1,108) 3,305 2,346
Changes in operating assets and liabilities:      
Accounts receivable (18,463) (28,967) 47,779
Contract assets, net 16,680 (8,707) 347
Inventories 8,019 (2,654) (13,226)
Operating lease right-of-use assets (4,505) (8,420) (8,817)
Prepaid expenses and other assets 15,223 (2,013) (1,218)
Accounts payable and other liabilities 22,851 (34,554) (52,315)
Income taxes, net (42,829) (4,501) (8,722)
Contract liabilities (5,079) (9,738) (8,379)
Operating lease liabilities (8,503) (5,263) (5,818)
Other non-current liabilities (406) (13,894) 3,285
Net cash provided by operating activities 472,198 327,252 367,081
Investing activities:      
Purchases of marketable securities 0 (160,198) (172,955)
Proceeds from sales of marketable securities 15,911 234,061 54,964
Proceeds from maturities of available-for-sale securities 0 157,729 176,833
Proceeds from sale of assets 16,881 0 0
Purchases of property, plant and equipment (36,348) (30,007) (30,339)
Acquisitions, net of cash acquired (1,362) (487,877) 25,703
Purchases of intangible assets (5,593) 0 0
Purchases of other investments (75) 0 0
Net cash provided by/(used in) investing activities (10,586) (286,292) 54,206
Financing activities:      
Proceeds from issuance of common stock 43,697 40,203 47,781
Repurchase of common stock (124,992) (160,001) (149,276)
Payment of cash dividend (126,599) (114,579) (103,407)
Distribution to controlling interest (1,847) (5,164) (266)
Payment of Excise Tax on Repurchase of Common Stock (261) 0 0
Purchase of noncontrolling interest in business combinations 0 (9,920) 0
Equity issued in connection with business combination 0 722 0
Shares repurchased for tax withholdings on vesting of restricted stock (37,236) (39,075) (31,144)
Payments for Deferred Consideration 0 0 500
Net cash used in financing activities (247,238) (287,814) (236,812)
Effect of foreign exchange rate changes on cash and cash equivalents 1,235 6,640 5,120
Net increase/(decrease) in cash, cash equivalents, and restricted cash 215,609 (240,214) 189,595
Cash, cash equivalents, and restricted cash at beginning of period 577,752 817,966 628,371
Cash, cash equivalents, and restricted cash at end of period 793,361 577,752 817,966
Supplemental disclosure:      
Cash paid for income taxes, net of refunds received 73,737 63,217 61,481
Non-cash investing activities:      
Change in property, plant, and equipment purchased, unpaid at period-end (2,830) 8,711 3,882
Accrual of unpaid stock repurchase excise tax 0 261 0
Equity issued in connection with business combination $ 0 $ 0 $ 21,198